AstraZeneca Pharma India (BOM:506820) 3-Year EBITDA Growth Rate : 4.10% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India 3-Year EBITDA Growth Rate?

AstraZeneca Pharma India's EBITDA per Share for the three months ended in Mar. 2024 was ₹23.22.

During the past 12 months, AstraZeneca Pharma India's average EBITDA Per Share Growth Rate was 24.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of AstraZeneca Pharma India was 73.60% per year. The lowest was -37.40% per year. And the median was 7.70% per year.

Competitive Comparison of AstraZeneca Pharma India's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca Pharma India's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where AstraZeneca Pharma India's 3-Year EBITDA Growth Rate falls into.

AstraZeneca Pharma India 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

AstraZeneca Pharma India (BOM:506820) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

AstraZeneca Pharma India 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Pharma India (BOM:506820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

ASTRAZEN:India

Address

Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website

https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines